Department of Medicine, University of Otago, Dunedin, New Zealand.
Biostatistics Centre, University of Otago, Dunedin, New Zealand.
JAMA Netw Open. 2023 Mar 1;6(3):e233005. doi: 10.1001/jamanetworkopen.2023.3005.
Little is known regarding the effect of poor sleep on health-related quality of life (HRQOL) in healthy children.
To determine the effect of induced mild sleep deprivation on HRQOL in children without major sleep issues.
DESIGN, SETTING, AND PARTICIPANTS: This prespecified secondary analysis focused on HRQOL, a secondary outcome of the Daily Rest, Eating, and Activity Monitoring (DREAM) randomized crossover trial of children who underwent alternating weeks of sleep restriction and sleep extension and a 1-week washout in between. The DREAM trial intervention was administered at participants' homes between October 2018 and March 2020. Participants were 100 children aged 8 to 12 years who lived in Dunedin, New Zealand; had no underlying medical conditions; and had parent- or guardian-reported normal sleep (8-11 hours/night). Data were analyzed between July 4 and September 1, 2022.
Bedtimes were manipulated to be 1 hour later (sleep restriction) and 1 hour earlier (sleep extension) than usual for 1 week each. Wake times were unchanged.
All outcome measures were assessed during both intervention weeks. Sleep timing and duration were assessed using 7-night actigraphy. Children and parents rated the child's sleep disturbances (night) and impairment (day) using the 8-item Pediatric Sleep Disturbance and 8-item Sleep-Related Impairment scales of the Patient-Reported Outcomes Measurement Information System questionnaire. Child-reported HRQOL was assessed using the 27-item KIDSCREEN questionnaire with 5 subscale scores and a total score. Both questionnaires assessed the past 7 days at the end of each intervention week. Data were presented as mean differences and 95% CIs between the sleep restriction and extension weeks and were analyzed using intention to treat and an a priori difference in sleep of at least 30 minutes per night.
The final sample comprised 100 children (52 girls [52%]; mean [SD] age, 10.3 [1.4] years). During the sleep restriction week, children went to sleep 64 (95% CI, 58-70) minutes later, and sleep offset (wake time) was 18 (95% CI, 13-24) minutes later, meaning that children received 39 (95% CI, 32-46) minutes less of total sleep per night compared with the sleep extension week in which the total sleep time was 71 (95% CI, 64-78) minutes less in the per-protocol sample analysis. Both parents and children reported significantly less sleep disturbance at night but greater sleep impairment during the day with sleep restriction. Significant standardized reductions in physical well-being (standardized mean difference [SMD], -0.28; 95% CI, -0.49 to -0.08), coping in a school environment (SMD, -0.26; 95% CI, -0.42 to -0.09), and total HRQOL score (SMD, -0.21; 95% CI, -0.34 to -0.08) were reported by children during sleep restriction, with an additional reduction in social and peer support (SMD, -0.24; 95% CI, -0.47 to -0.01) in the per-protocol sample analysis.
Results of this secondary analysis of the DREAM trial indicated that even 39 minutes less of sleep per night for 1 week significantly reduced several facets of HRQOL in children. This finding shows that ensuring children receive sufficient good-quality sleep is an important child health issue.
Australian New Zealand Clinical Trials Registry: ACTRN12618001671257.
关于睡眠质量差对健康相关生活质量(HRQOL)的影响,在健康儿童中知之甚少。
确定诱导轻度睡眠剥夺对无主要睡眠问题儿童的 HRQOL 的影响。
设计、设置和参与者:本预先指定的次要分析侧重于 HRQOL,这是 Daily Rest、Eating、and Activity Monitoring(DREAM)随机交叉试验的次要结果之一,该试验对儿童进行了交替的睡眠限制和睡眠延长周以及中间一周的洗脱期。DREAM 试验干预是在 2018 年 10 月至 2020 年 3 月期间在参与者家中进行的。参与者为 100 名 8 至 12 岁的儿童,居住在新西兰达尼丁;没有潜在的医疗条件;并且父母或监护人报告正常睡眠(每晚 8-11 小时)。数据于 2022 年 7 月 4 日至 9 月 1 日进行分析。
调整就寝时间,每晚比平时晚 1 小时(睡眠限制)和早 1 小时(睡眠延长),持续 1 周。醒来时间不变。
所有结果测量均在两个干预周内进行。睡眠时间和持续时间使用 7 夜活动记录仪进行评估。儿童和父母使用患者报告的结果测量信息系统问卷的 8 项儿科睡眠障碍和 8 项睡眠相关障碍量表评估儿童的睡眠障碍(夜间)和障碍(白天)。儿童报告的 HRQOL 使用 27 项 KIDSCREEN 问卷进行评估,该问卷有 5 个子量表评分和一个总分。两个问卷在每个干预周结束时评估过去 7 天的数据。结果表示为睡眠限制和延长周之间的平均差异和 95%置信区间,并使用意向治疗和至少 30 分钟/夜的睡眠差异进行了预先分析。
最终样本包括 100 名儿童(52 名女孩[52%];平均[SD]年龄为 10.3[1.4]岁)。在睡眠限制周期间,儿童入睡时间延迟 64(95%CI,58-70)分钟,睡眠结束时间(醒来时间)延迟 18(95%CI,13-24)分钟,这意味着与睡眠延长周相比,儿童每晚总共少睡 39(95%CI,32-46)分钟,在符合方案样本分析中,睡眠时间总共少了 71(95%CI,64-78)分钟。父母和孩子都报告说,在睡眠限制期间,夜间睡眠干扰明显减少,但白天睡眠障碍明显增加。儿童报告的身体幸福感(标准化均数差[SMD],-0.28;95%CI,-0.49 至 -0.08)、在学校环境中应对能力(SMD,-0.26;95%CI,-0.42 至 -0.09)和总 HRQOL 评分(SMD,-0.21;95%CI,-0.34 至 -0.08)均显著降低,在符合方案样本分析中,社会和同伴支持(SMD,-0.24;95%CI,-0.47 至 -0.01)也有降低。
DREAM 试验的这项二次分析结果表明,即使每周减少 39 分钟的睡眠时间也会显著降低儿童的几个 HRQOL 方面。这一发现表明,确保儿童获得充足的高质量睡眠是一个重要的儿童健康问题。
澳大利亚新西兰临床试验注册中心:ACTRN12618001671257。